pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
NITROFURANTOIN MONOHYDRATE/ MACROCRYSTALLINE
NITROFURANTOIN MONOHYDRATE/ MACROCRYSTALLINE (NITROFURANTOIN MONOHYDRATE/MACROCRYSTALLINE)
ALMATICA
0 catalysts
NITROGEN
NITROGEN (NITROGEN)
LINDE NORTH AMERICA INC
0 catalysts
Preclinical
NIV-001
Stroke
Neuro-Innovators LLC
0 catalysts
NIVESTYM
NIVESTYM (FILGRASTIM-AAFI)
Hospira Inc
0 catalysts
← prev
page 130 of 271
next →
131
Pain89
Neurology1
Phase 1
NKT-3964
Adenocarcinoma Of The Gastroesophageal Junction
NiKang Therapeutics Inc
0 catalysts
Phase 1
NLX-101
Fragile X Syndrome
Neurolixis Inc
0 catalysts
Preclinical
NM-1014
Autism Spectrum Disorder (ASD)
Nova Mentis BioTech Corp
0 catalysts
Preclinical
NM-1020
Fragile X Syndrome
Nova Mentis BioTech Corp
0 catalysts
Phase 1
NM-5072
Paroxysmal Nocturnal Hemoglobinuria
NovelMed Therapeutics Inc
0 catalysts
Phase 1
NM-6603
Colorectal Cancer
Nucmito
0 catalysts
Phase 2
NMDP-02
ignaseclant
Spinal Muscular Atrophy (SMA)
NMD Pharma AS
0 catalysts
Phase 2
NMDP-08
ignaseclant
Charcot-Marie-Tooth Disease Type I
NMD Pharma AS
0 catalysts
Phase 1
NMS-812
Refractory Acute Myeloid Leukemia
Nerviano Medical Sciences SRL
0 catalysts
Phase 1
NN-3201
Adenoid Cystic Carcinoma (ACC)
Novelty Nobility Inc
0 catalysts
Preclinical
NNDA-001
Parkinson's Disease
Neoneuron LLC
0 catalysts
Preclinical
NNI-351
Fragile X Syndrome
NeuroNascent Inc
0 catalysts
Phase 1
NNI-362
Alzheimer's Disease
NeuroNascent Inc
0 catalysts
Phase 1
NO-13065
Obesity
Otsuka Pharmaceutical Co Ltd
0 catalysts
Preclinical
NOD-2
Unspecified Cancer
Nodus Oncology Ltd
0 catalysts
Preclinical
NOD-800
Geographic Atrophy
Nanoscope Therapeutics Inc
0 catalysts
NORELGESTROMIN AND ETHINYL ESTRADIOL
NORELGESTROMIN AND ETHINYL ESTRADIOL (NORELGESTROMIN AND ETHINYL ESTRADIOL)
ZYDUS PHARMS
0 catalysts
NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE
NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE (NOREPINEPHRINE BITARTRATE)
Baxter Healthcare Corp
0 catalysts
NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE
NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE (NOREPINEPHRINE BITARTRATE)
Sagent Pharmaceuticals Inc
0 catalysts
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL)
GLENMARK PHARMS LTD
0 catalysts
NORGESIC
NORGESIC (ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE)
GALT PHARMS
0 catalysts
NORGESTIMATE AND ETHINYL ESTRADIOL
NORGESTIMATE AND ETHINYL ESTRADIOL (ETHINYL ESTRADIOL)
Mylan Pharmaceuticals Inc
0 catalysts
NORMOSOL-R
NORMOSOL-R (SODIUM CHLORIDE, SODIUM ACETATE ANHYDROUS, SODIUM GLUCONATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE)
OTSUKA ICU MEDCL
0 catalysts
Preclinical
NOS-01
Phelan-McDermid Syndrome (22q13.3 Deletion Syndrome)
Nospharma
0 catalysts
Phase 2
NOUS-209
Gastric Cancer
Nouscom AG
0 catalysts
Phase 1
NOVA-1010
Schizophrenia
Novastage Pharmaceuticals (Shenzhen) Ltd
0 catalysts